Metformin for polycystic ovary syndrome
Pro Research Analysisby 
Searched over 200M research papers
Metformin and Polycystic Ovary Syndrome: Ovulation and Fertility Outcomes
Metformin is widely studied for its role in improving ovulation in women with polycystic ovary syndrome (PCOS). Multiple systematic reviews and meta-analyses show that metformin significantly increases ovulation rates compared to placebo, and its effectiveness is even greater when combined with clomiphene citrate, a common ovulation induction agent 18. This combination also leads to higher pregnancy rates than clomiphene alone 18. Metformin is especially beneficial as an adjunctive medication for ovulation induction in both low and high complexity assisted reproduction treatments, including in vitro fertilization .
Metformin’s Impact on Metabolic and Hormonal Features in PCOS
PCOS is closely linked to insulin resistance and metabolic disturbances. Metformin helps reduce fasting insulin levels, blood pressure, and low-density lipoprotein (LDL) cholesterol in women with PCOS 18. It also improves insulin resistance, menstrual regularity, and androgen levels, particularly in women who are overweight or have clear signs of insulin resistance 349. However, metformin does not have a significant effect on body mass index (BMI) or waist-to-hip ratio 18. Its use may also improve cardiovascular risk factors and markers of subclinical inflammation 679.
Safety, Side Effects, and Use in Pregnancy
Metformin is generally well tolerated, with the most common side effects being mild gastrointestinal symptoms such as nausea and vomiting 128. Serious adverse effects are rare, and there is no evidence of teratogenicity, making metformin considered safe for use during pregnancy in women with PCOS 24. Some studies suggest metformin may reduce the risk of early pregnancy loss and preterm birth, but its effects on gestational diabetes and preeclampsia are inconsistent . The long-term safety of metformin use in young women and its impact on offspring remain unclear, and more research is needed in these areas 124.
Limitations and Considerations in Metformin Use for PCOS
While metformin is effective for improving ovulation and some metabolic features, it is not recommended as a first-line therapy for weight loss, ovulation induction, or for treating clinical hyperandrogenic symptoms like hirsutism or acne 4610. Its benefits are most pronounced in women with insulin resistance or those at risk for metabolic complications 349. There is considerable variability in individual response to metformin, possibly due to genetic factors, and further research is needed to identify which women will benefit most . Metformin should be used as an adjunct to lifestyle modifications, such as increased exercise and improved diet, rather than as a replacement 18.
Conclusion
Metformin is a valuable treatment option for women with PCOS, particularly for improving ovulation and certain metabolic parameters, especially in those with insulin resistance. It is most effective when used alongside other therapies and lifestyle changes. While generally safe, its long-term effects and the best candidates for therapy require further study. Metformin is not a universal solution for all PCOS symptoms, but it remains an important tool in the management of this complex condition.
Sources and full results
Most relevant research papers on this topic